Barclays Upgrade Sends PHAT Surging—But Volume Remains Unconvincing

What's driving PHAT stock higher in pre-market sessions?

Phathom Pharmaceuticals (PHAT) has surged over 10.8% in pre-market trading, with shares jumping from $10.58 to $11.73. The move follows a recent analyst rating upgrade from Barclays, which raised its stance on PHAT from Equal-Weight to Overweight and increased the price target from $16 to $18. Analyst Glen Santangelo cited renewed optimism in Voquezna sales and the company’s focus on gastrointestinal disease treatment as key drivers.

This upgrade adds to a broader positive momentum in U.S. equity futures, with the Nasdaq and S&P 500 both rising by nearly 0.6%. However, PHAT’s performance stands out as one of the most dramatic moves of the session.

What factors could support or weaken the move?

While the upgrade from Barclays is a clear catalyst, the strength of the move is tempered by limited participation. Volume data for PHAT is not currently available for this session, but historical levels suggest that today's trading is unlikely to break through 6.7 million shares unless there is a surge in demand.

Technically, the stock is trading at 11.73, placing it in the mid-range for both 20-day and 60-day periods. PHAT has faced resistance at $12.00 and support near $11.00. The RSI sits at 43.44, indicating the stock is neither overbought nor oversold, but the ATR of 0.73 suggests increased volatility.

That said, the market structure still favors a mean reversion. PHAT’s recent price action reflects a range-bound pattern, with the 20-day moving average at $10.80 and the 50-day at $12.14. If the stock continues to rise, it will need to hold above the 20-day line and show follow-through buying in the regular session.

What levels and signals should investors watch next?

The key technical level to watch is $12.00. A close above this level with strong volume would signal a potential breakout and could validate the upgrade from Barclays. Conversely, a drop below $11.00 would raise concerns about the sustainability of the move and potentially trigger a pullback toward the 20-day moving average at $10.80.

In practice, investors should also monitor the volume profile over the next few days. A lack of follow-through buying or a sudden drop in trading interest may suggest that today’s move is more speculative than sustainable.

Crucially, the stock faces a critical juncture. If PHAT can maintain its position above $11.00 and show signs of broadening participation, it could continue its upward trajectory. But a failure to confirm the breakout could lead to a reversal in the near term.

At the end of the day, this move is driven by a strong analyst rating, but the strength of the move remains unconfirmed by volume. Investors should keep an eye on the $12.00 and $11.00 levels for the next set of signals.

( support and resistance levels)